Understanding and Disclosing Competing Interests in Research Table of Contents Understanding and Disclosing Competing Interests in Research What are Competing Interests? Types of Competing Interests Why Disclosure is Essential The …
translational research
-
-
Social Interaction in Early Life Significantly Shapes Infant Gut Microbiome Development and Recovery 30 January 2026 – Emerging research highlights the profound impact of social interactions within nursery settings on …
-
Okay, I will analyze the provided author affiliation list and attempt to verify and correct any inaccuracies using web searches. Here’s a breakdown of the affiliations and authors, with notes …
-
Bridging the Gap: Overcoming Challenges in Translational Research Table of Contents Bridging the Gap: Overcoming Challenges in Translational Research The Stalled Pipeline: Identifying Key Obstacles The Early-Career Researcher Dilemma Re-evaluating …
-
Summary of Study Methodology: TLC-2716 Phase 1 Clinical Trial This text details the methodology of a Phase 1 clinical trial investigating the safety,pharmacokinetics (PK),and pharmacodynamics of a drug called TLC-2716. …
-
Genetic Predisposition to Retinal Disease Doesn’t Guarantee Diagnosis, New Research Finds Table of Contents Genetic Predisposition to Retinal Disease Doesn’t Guarantee Diagnosis, New Research Finds Lower Penetrance Than Expected Implications …
-
Patient disposition Table of Contents Patient disposition Study Design and Outcomes in Vagus Nerve Stimulation for Rheumatoid Arthritis secondary outcomes Exploratory outcomes Efficacy Safety Following approval by the institutional review …
-
Physical Activity and Alzheimer’s Disease Risk: A Proactive Approach Mounting evidence suggests a strong link between physical activity and a reduced risk of developing Alzheimer’s disease, even in its earliest, …
-
The Future of HIV Research and U.S. Scientific Leadership Published: 2025/10/24 15:01:52 The continued progress in HIV research,and the United States’ position as a global leader in scientific innovation,require sustained …
-
Nivolumab and Relatlimab Combination Shows No Notable Benefit in Resected Melanoma Recent findings from the RELATIVITY-098 trial, presented at the ASCO 2025 Annual Meeting and the ESMO Congress 2025, indicate …